DE60119367D1 - Zellulosederivatkapsel, wie z. b. hpmc, die benzimidazolderivat enthaelt, wie z.b. omeprazol - Google Patents

Zellulosederivatkapsel, wie z. b. hpmc, die benzimidazolderivat enthaelt, wie z.b. omeprazol

Info

Publication number
DE60119367D1
DE60119367D1 DE60119367T DE60119367T DE60119367D1 DE 60119367 D1 DE60119367 D1 DE 60119367D1 DE 60119367 T DE60119367 T DE 60119367T DE 60119367 T DE60119367 T DE 60119367T DE 60119367 D1 DE60119367 D1 DE 60119367D1
Authority
DE
Germany
Prior art keywords
omeprazol
derivat
hpmc
cellulose derivative
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE60119367T
Other languages
English (en)
Other versions
DE60119367T2 (de
Inventor
Judita Sirca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lek Pharmaceuticals dd
Original Assignee
Lek Pharmaceuticals dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20432767&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60119367(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lek Pharmaceuticals dd filed Critical Lek Pharmaceuticals dd
Application granted granted Critical
Publication of DE60119367D1 publication Critical patent/DE60119367D1/de
Publication of DE60119367T2 publication Critical patent/DE60119367T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60119367T 2000-11-20 2001-11-20 Zellulosederivatkapsel, wie z. b. hpmc, die benzimidazolderivat enthaelt, wie z.b. omeprazol Revoked DE60119367T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200000282A SI20720A (sl) 2000-11-20 2000-11-20 Nov farmacevtski pripravek v obliki celuloznih kapsul uporaben za derivate benzimidazola
SI200000282 2000-11-20
PCT/SI2001/000031 WO2002039980A2 (en) 2000-11-20 2001-11-20 Capsule of cellulose derivatives such as hpmc containing benzimidazole derivatives such as omeprazole

Publications (2)

Publication Number Publication Date
DE60119367D1 true DE60119367D1 (de) 2006-06-08
DE60119367T2 DE60119367T2 (de) 2007-04-19

Family

ID=20432767

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60119367T Revoked DE60119367T2 (de) 2000-11-20 2001-11-20 Zellulosederivatkapsel, wie z. b. hpmc, die benzimidazolderivat enthaelt, wie z.b. omeprazol

Country Status (9)

Country Link
US (2) US20040029924A1 (de)
EP (1) EP1335709B1 (de)
AT (1) ATE324873T1 (de)
AU (2) AU2002214524B2 (de)
DE (1) DE60119367T2 (de)
ES (1) ES2263675T3 (de)
PL (1) PL360972A1 (de)
SI (1) SI20720A (de)
WO (1) WO2002039980A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
EP1663173A1 (de) * 2003-09-25 2006-06-07 Natco Pharma Limited Enterische weichgelatinekapsel enthaltend esomeprazole und verfahren zu ihrer herstellung
WO2005034924A1 (en) * 2003-10-14 2005-04-21 Natco Pharma Limited Enteric coated pellets comprising esomeprazole, hard gelatin capsule containing them, and method of preparation
JPWO2005084649A1 (ja) * 2004-03-04 2007-11-29 武田薬品工業株式会社 安定なカプセル剤
CA2570916C (en) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
WO2008018825A1 (en) * 2006-08-10 2008-02-14 Astrazeneca Ab Oral polyvinyl alcohol capsules comprising proton pump inhibitors
CN116251075A (zh) * 2023-03-31 2023-06-13 江苏慧聚药业股份有限公司 一种兰索拉唑肠溶胶囊及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5264223A (en) * 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5431917A (en) * 1992-10-08 1995-07-11 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SI9700186B (sl) * 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
ZA9810765B (en) * 1998-05-28 1999-08-06 Ranbaxy Lab Ltd Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
EP1072258A1 (de) * 1999-07-28 2001-01-31 Greither, Peter Eine Kapsel für die Freisetzung von Bakterien, enthaltend ein Bakterienlyophilisat und ein Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
WO2002039980A2 (en) 2002-05-23
US20090226511A1 (en) 2009-09-10
EP1335709A2 (de) 2003-08-20
EP1335709B1 (de) 2006-05-03
AU2002214524B2 (en) 2007-03-01
DE60119367T2 (de) 2007-04-19
US20040029924A1 (en) 2004-02-12
AU1452402A (en) 2002-05-27
PL360972A1 (en) 2004-09-20
ES2263675T3 (es) 2006-12-16
WO2002039980A3 (en) 2002-07-11
SI20720A (sl) 2002-06-30
ATE324873T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
AR016827A1 (es) PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
NO20023313D0 (no) Nye substituerte benzimidazol doseringsformer og fremgangsmåte for anvendelse av samme
NO20022058D0 (no) Farmasöytiske sammensetninger
ES2165833T1 (es) Composicion farmaceutica revestida enterica y procedimiento de fabricacion.
YU23402A (sh) Kompozicije sa kontrolisanim oslobađanjem koje sadrže nimezulid
IL139227A0 (en) N-substituted aminotetralins as ligands for the neuropeptide yy5 receptor useful in the treatment of obesity and other disorders
IT1282352B1 (it) Composizione farmaceutica, in particolare essiccata mediante congelamento, per somministrazione orale di ondansetron e metodo per
BG105857A (en) Pregelatinized starch in a controlled release formulation
YU21999A (sh) Farmaceutske smese i postupak za njihovo dobijanje
EA200000246A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
IL143375A0 (en) Sustained release matrix systems for highly soluble drugs
DK0994710T4 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzylhydrylpiperazin og en cyclodextrin
DE60119367D1 (de) Zellulosederivatkapsel, wie z. b. hpmc, die benzimidazolderivat enthaelt, wie z.b. omeprazol
MXPA04003346A (es) Formulacion de dosis oral de disolucion instantanea.
LV10268A (lv) Terapeitiski aktivs benzimidazols un ta iegusanas panemiens
SE8901003D0 (sv) Snabbloesliga preparat
AR025060A1 (es) Formulaciones farmaceuticas en capsulas de hidroxipropilmetilcelulosa
AR021086A1 (es) Omega-amidas de n-arilsulfonil-aminoacidos, un procedimiento para su preparacion, medicamento, uso de dichos compuestos para la preparacion de un medicamento y procedimiento para la preparacion de un medicamento.
YU47044B (sh) Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
NO178336C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter
ATE254851T1 (de) Iod-herstellungszusammensetzung
CO5170463A1 (es) Formas polimorfas de un citrato de azobiciclo [2,2,2]octan- 3-amina y sus composiciones farmaceuticas
ATE397447T1 (de) Feste paroxetin enthaltende zubereitungen
AR027038A1 (es) Metodo y composicion para el tratamiento del dolor
ECSP003607A (es) Formulaciones farmaceuticas en capsulas de hidroxipropilmetilcelulosa

Legal Events

Date Code Title Description
8363 Opposition against the patent
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8331 Complete revocation